{
  "trial_id": "NCT02505243",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "HCV-infected patients",
      "label": "met",
      "evidence": "patient text"
    },
    {
      "criterion": "Patient must be treated with ribavirin.",
      "label": "met",
      "evidence": "patient text"
    },
    {
      "criterion": "Patient must be treated with one or more DAAs (simeprevir, sofosbuvir, daclatasvir, ledipasvir, paritaprevir, ombitasvir, or dasabuvir).",
      "label": "met",
      "evidence": "patient text"
    },
    {
      "criterion": "At least 18 years of age at start of treatment.",
      "label": "met",
      "evidence": "patient text"
    }
  ],
  "exclusion": [
    {
      "criterion": "None",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "Patient has chronic HCV infection and is on combination therapy with IFN, RBV, and DAAs. He meets all inclusion criteria.",
  "_meta": {
    "topic_id": "27",
    "trial_id": "NCT02505243",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}